Summary by NEST360

NEST360 researchers published a paper in BMC Pediatrics on the evaluation of commercial point-of-care glucometers for detecting and monitoring of neonatal hypoglycemia in resource-constrained settings.

According to the UNICEF | NEST360 Target Product Profile for Glucometers, hypoglycemia is a common metabolic problem in newborns and can result in neurologic complications if left untreated. Small and premature newborns are at increased risk for hypoglycemia. Monitoring blood glucose concentration enables clinicians to intervene with supplemental glucose for at-risk infants. Most common point-of-care glucometers are designed to be accurate at high glucose ranges for management of adult diabetes; few are intended for use or accurate in the low glucose concentrations seen in hypoglycemic newborns.